Review of magnetic resonance spectroscopy in the liver and the pancreas

Topics in Magnetic Resonance Imaging

Volumn 20, Issue 2, 2009, Pages 89-97

  Perman, William H ^a   Cem Balci, Numan ^a   Akduman, Isin ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Choline; Lipid; Liver; Magnetic resonance spectroscopy; MRS; Pancreas

Indexed keywords

ADIPOSE TISSUE; BENIGN TUMOR; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; FATTY LIVER; HEPATITIS; HUMAN; LIVER; MALIGNANT NEOPLASTIC DISEASE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PANCREAS; PANCREATITIS; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; REVIEW;

BIOLOGICAL MARKERS; COMPUTER SIMULATION; DIAGNOSIS, COMPUTER-ASSISTED; HUMANS; LIPIDS; LIVER; LIVER DISEASES; MAGNETIC RESONANCE SPECTROSCOPY; MODELS, BIOLOGICAL; PANCREAS; PANCREATIC DISEASES;

EID: 74249119937     PISSN: 08993459     EISSN: None     Source Type: Journal    
DOI: 10.1097/RMR.0b013e3181c422f1     Document Type: Review

References (25)

1. Dixon WT. Simple proton spectroscopic imaging. Radiology. 1984;153:189-194.
2. Heiken JP, Lee JK, Dixon WT. Fatty infiltration of the liver: evaluation by proton spectroscopic imaging. Radiology. 1985;157:707-710.
3. Mitchell DG, Kim I, Chang TS, et al. Fatty liver. Chemical shift phase-difference and suppression magnetic resonance imaging techniques in animals, phantoms, and humans. Invest Radiol. 1991;26:1041-1052.
4. Longo R, Ricci C, Masutti F, et al. Fatty infiltration of the liver. Quantification by 1H localized magnetic resonance spectroscopy and comparison with computed tomography. Invest Radiol. 1993;28:297-302.
5. Thomsen C, Becker U,Winkler K, et al. Quantification of liver fat using magnetic resonance spectroscopy. Magn Reson Imaging. 1994;12: 487-495.
6. Longo R, Pollesello P, Ricci C, et al. Proton MR spectroscopy in quantitative in vivo determination of fat content in human liver steatosis. J Magn Reson Imaging. 1995;5:281-285.
7. Ordige RJ, Bendal MR, Gordon RE, et al. Volume detection for in-vivo spectroscopy. In: Govil G, Ketrapal CL, Saran A, eds. Magnetic Resonance in Biology and Medicine. New Delhi, India: Tata-McGraw-Hill; 1985:387-397.
8. Bottomley PA. Spatial localization in NMR spectroscopy in vivo. Ann N Y Acad Sci. 1987;508:333-348.
9. Haase A, Frahm J, Matthaei D, et al. MR imaging using stimulated echoes (STEAM). Radiology. 1986;160:787-790.
10. Moonen CT, Von Kienlin M, Van Zijl PC, et al. Comparison of single-shot localization methods (STEAM and PRESS) for in vivo proton NMR spectroscopy. NMR Biomed. 1989;2:201-208.
11. Pollesello P, Masutti F, Croce LS, et al. 1H NMR spectroscopic studies of lipid extracts from human fatty liver. Biochem Biophys Res Commun. 1993;192:1217-1222.
12. De La Maza MP, Hirsch S, Nieto S, et al. Fatty acid composition of liver total lipids in alcoholic patients with and without liver damage. Alcohol Clin Exp Res. 1996;20:1418-1422.
13. Johnson NA, Walton DW, Sachinwalla T, et al. Noninvasive assessment of hepatic lipid composition: advancing understanding and management of fatty liver disorders. Hepatology. 2008;47:1513-1523.
14. Fischbach F, Schirmer T, Thormann M, et al. Quantitative proton magnetic resonance spectroscopy of the normal liver and malignant hepatic lesions at 3.0 Tesla. Eur Radiol. 2008;18:2549-2558.
15. Orlacchio A, Bolacchi F, Cadioli M, et al. Evaluation of the severity of chronic hepatitis C with 3-T1H-MR spectroscopy. AJR Am J Roentgenol. 2008;190:1331-1339.
16. Tyszka JM, Silverman JM. Navigated single-voxel proton spectroscopy of the human liver. Magn Reson Med. 1998;39:1-5.
17. Vuppalanchi R, Cummings OW, Saxena R, et al. Relationship among histologic, radiologic, and biochemical assessments of hepatic steatosis: a study of human liver samples. J Clin Gastroenterol. 2007;41:206-210.
18. Howe FA, Barton SJ, Cudlip SA, et al. Metabolic profiles of human brain tumors using quantitative in vivo 1H magnetic resonance spectroscopy. Magn Reson Med. 2003;49:223-232.
19. Mukherji SK, Schiro S, Castillo M, et al. Proton MR spectroscopy of squamous cell carcinoma of the extracranial head and neck: in vitro and in vivo studies. AJNR Am J Neuroradiol. 1997;18:1057-1072.
20. Katz-Brull R, Lavin PT, Lenkinski RE. Clinical utility of proton magnetic resonance spectroscopy in characterizing breast lesions. J Natl Cancer Inst. 2002;94:1197-1203.
21. Kvistad KA, Bakken IJ, Gribbestad IS, et al. Characterization of neoplastic and normal human breast tissues with in vivo (1)H MR spectroscopy. J Magn Reson Imaging. 1999;10:159-164.
22. Jagannathan NR, Kumar M, Seenu V, et al. Evaluation of total choline from in-vivo volume localized proton MR spectroscopy and its response to neoadjuvant chemotherapy in locally advanced breast cancer. Br J Cancer. 2001;84:1016-1022.
23. Li CW, Kuo YC, Chen CY, et al. Quantification of choline compounds in human hepatic tumors by proton MR spectroscopy at 3 T. Magn Reson Med. 2005;53:770-776.
24. Cho SG, Kim MY, Kim HJ, et al. Chronic hepatitis: in vivo proton MR spectroscopic evaluation of the liver and correlation with histopathologic findings. Radiology. 2001;221:740-746.
25. Cho SG, Lee DH, Lee KY, et al. Differentiation of chronic focal pancreatitis from pancreatic carcinoma by in vivo proton magnetic resonance spectroscopy. J Comput Assist Tomogr. 2005;29:163-169.